The biggest macro trend in investing is the rise of so-called "passive investing." But while this may have advantages for the individual investor, it raises a whole new host of issues, such as elevating the role of index designers, and decreasing the emphasis on studying individual companies. On this week's Odd Lots podcast, we speak with Bernstein's Inigo Fraser-Jenkins who once wrote a note that said passive investing is "worse for society than Marxism."

See omnystudio.com/listener for privacy information.

The past couple months have seen the return of volatility in markets. On this edition of Odd Lots, we speak to Chris Cole, the founder of Artemis Capital Management and a long-time watcher of volatility. Cole has argued that a lot of the investment strategies we take for granted in markets essentially amount to a giant bet that volatility will remain low. So what happens when vol starts to come back? 

See omnystudio.com/listener for privacy information.

With assets like stocks and bonds, there are clear techniques you can use to value them. But what about currencies? They don't produce cash flows. They don't offer any particular claim on assets. They're all priced relative to other currencies. So how do you go about determining their value? 

See omnystudio.com/listener for privacy information.

Paul Volcker is widely-regarded as single-handedly halting a period of severe inflation in the U.S. during the late 1970s and early 1980s. But the former chairmen of the Federal Reserve’s reputation wasn't always so secure. So how does he view his legacy? Christine Harper, the editor of Bloomberg Markets, spent two years working with Volcker to co-author his autobiography, “Keeping At It: The Quest for Sound Money and Good Government.” 

See omnystudio.com/listener for privacy information.

For years, a common mantra among corporate executives has been that "the blockchain," the technology underlying Bitcoin and other cryptocurrencies, is where the real value lies in the future. But on this week's episode of Odd Lots, we speak to Angus Champion de Crespigny, who formerly advised companies on how to use blockchain technology. He now believes that ultimately it won't get them anywhere. 

See omnystudio.com/listener for privacy information.

So-called "unicorns" have become household names in recent years. Multi-billion dollar companies like AirBNB, Uber, and WeWork have become known for phenomenal growth, extraordinary valuations, and a general dearth of profits. That means these companies have been reliant on accommodative financial conditions to maintain their growth. So how might this all come to an end? 

See omnystudio.com/listener for privacy information.

What’s the most sure-fire way to get a flight upgrade? How can you find the best, secret local restaurants by asking just one question? What's the first thing you should do when you get into a hotel room? On Bloomberg's new podcast Travel Genius, we'll give you those answers—and plenty more—as hosts Nikki Ekstein and Mark Ellwood quiz the world’s most experienced globetrotters for their tried-and-true travel hacks. Listen weekly, and even your work trips will go from a necessary evil to an expert art form. Plus, you'll be padding out your bucket list with dreams of amazing future vacations. 

See omnystudio.com/listener for privacy information.

If there's one person associated with the term "Rogue Trader" it's Nick Leeson, who singlehandedly brought down Barings Bank in the early 90s, following a series of efforts to cover up bad trades. After the collapse of the bank, he spent time in a Singapore prison. On this week's podcast, we talk to Nick about the experience, what he learned, and how he managed to rebuild his life.

Correction: Corrects the spelling of Barings Bank in the description of the podcast.

See omnystudio.com/listener for privacy information.

Where does a medical cure come from? 100 years ago, it wasn't uncommon for scientists to test medicines by taking a dose themselves. As medical technologies get cheaper and more accessible, patients and DIY tinkerers are trying something similar—and mainstream medicine is racing to catch up. Prognosis explores the leading edge of medical advances, and asks who gets—or should get—access to them. We look at how innovation happens, when it fails, and what it means to the people with a disease trying to feel better, live longer, or avoid death.

See omnystudio.com/listener for privacy information.

Eurodollars have nothing to do with the euro-dollar exchange rate. Instead, they're effectively a source of dollars that operates outside the control of the U.S. Jeff Snider, Head of Global Research at Alhambra, has a theory that recent market volatility might have its roots in some eurodollar drama. 

See omnystudio.com/listener for privacy information.